KROSKeros Therapeutics, Inc.
11.03USD-0.63%Mkt Cap: 218.69M $P/E: —3d ago
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-be…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap218.69M $
Enterprise Value-24.77M $
Revenue (TTM)15.01M $
Gross Profit-58.34M $
Net Income (TTM)87.01M $
Revenue/Share0.5610 USD
Last Price11.03 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.66
PEG—
EV/EBITDA0.26
EV/Revenue-1.65
P/S14.46
P/B0.83
EPS (TTM)-3.18
EPS (Forward)-6.61
52W Range
9.69010% of range22.55
52W High22.55 USD
52W Low9.690 USD
Profitability
Gross Margin0.00%
Oper. Margin-655.84%
EBITDA Margin0.00%
Profit Margin35.65%
ROE28.70%
ROA25.74%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF107.50M $
CapEx (TTM)1.55M $
FCF Margin-180.99%
FCF Yield-12.43%
Net Debt-241.88M $
Net Debt/EBITDA2.50
Balance Sheet
Debt/Equity0.06
Current Ratio21.96
Quick Ratio21.47
Book Value/Sh13.23 USD
Cash/Share12.99 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.83 USD
Upside (mean)+79.8%
Target Range16.00 USD – 25.00 USD
$16.00+79.8% to mean$25.00
# Analysts6
Ownership
Shares Out.19.83M
Float17.81M
Insiders4.02%
Institutions95.32%
Short Interest
Short Ratio4.6d
Short % Float5.72%
Short % Out.4.97%
Shares Short985.59K
Short (prev mo.)1.03M
Technical
SMA 5010.65 (+3.6%)
SMA 20013.95 (-20.9%)
Beta1.01
S&P 52W Chg18.16%
Avg Vol (30d)206.58K
Avg Vol (10d)217.57K
Technical Indicators
RSI (14)54.8
MACD0.0566
MACD Signal-0.0179
MACD Hist.+0.0746
BB Upper11.28 USD
BB Middle10.44 USD
BB Lower9.600 USD
BB Width16.09%
ATR (14)0.5245 USD
Vol Ratio (20d)0.74x